Suven Life Sciences Limited (BOM:530239)

India · Delayed Price · Currency is INR

279.35

+12.45 (4.66%)

At close: May 29, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Research and Development Services	71.15M	66.56M	116.93M	135.95M	119.51M
Research and Development Services Growth	6.89%	-43.08%	-13.99%	13.76%	-15.08%
Total	71.15M	66.56M	116.93M	135.95M	119.51M
Total Growth	6.89%	-43.08%	-13.99%	13.76%	-15.08%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	47.31M	28.97M	83.92M	62.98M
India Growth	63.32%	-65.48%	33.24%	22.90%
United States of America (USA)	632.00K	50.74M	38.54M	44.43M
United States of America (USA) Growth	-98.75%	31.68%	-13.26%	-45.47%
Europe	3.49M	24.39M	2.04M	1.39M
Europe Growth	-85.70%	1095.64%	46.76%	-32.59%
Rest of the World	15.13M	12.83M	10.90M	9.64M
Rest of the World Growth	17.94%	17.75%	13.00%	-
Total	66.56M	116.93M	135.39M	118.44M
Total Growth	-43.08%	-13.64%	14.31%	-12.12%

Source: S&P Global Market Intelligence.